diazoxide Oral suspension 50 mg/ml - 30 ml

Established in 1994, this innovative R&D and manufacturing company focuses on the pharmaceutical and health sectors. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards, operating sophisticated drug production facilities that meet cGMP specifications from regulatory bodies such as NMPA, FDA, and EMA. The company's diverse portfolio includes biologics, small molecules, synthetic biologics, and special traditional Chinese medicines (TCMs), with over 300 product approvals across various categories. Its products are distributed in more than 40 countries and regions, including Singapore, South Korea, Italy, and China.